Mettler-Toledo International (NYSE:MTD) Upgraded at Citigroup

Citigroup upgraded shares of Mettler-Toledo International (NYSE:MTD) from a sell rating to a neutral rating in a report issued on Wednesday, MarketBeat reports. They currently have $1,300.00 price objective on the medical instruments supplier’s stock, up from their prior price objective of $1,200.00.

A number of other brokerages have also recently issued reports on MTD. Stifel Nicolaus decreased their price objective on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a report on Monday, November 11th. Wells Fargo & Company lowered their price objective on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a report on Monday, November 11th. Evercore ISI upped their target price on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 1st. Finally, Robert W. Baird dropped their price target on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a research report on Monday, November 11th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $1,351.25.

Mettler-Toledo International Trading Up 0.0 %

MTD opened at $1,276.98 on Wednesday. Mettler-Toledo International has a 1 year low of $1,115.64 and a 1 year high of $1,546.93. The stock has a fifty day moving average price of $1,305.85 and a 200 day moving average price of $1,377.40. The stock has a market cap of $26.94 billion, a price-to-earnings ratio of 34.43, a PEG ratio of 4.19 and a beta of 1.13.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 EPS for the quarter, beating the consensus estimate of $10.00 by $0.21. The business had revenue of $954.54 million during the quarter, compared to analysts’ expectations of $941.93 million. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. As a group, sell-side analysts forecast that Mettler-Toledo International will post 40.42 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Mettler-Toledo International news, Director Elisha W. Finney sold 76 shares of Mettler-Toledo International stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the sale, the director now directly owns 240 shares of the company’s stock, valued at approximately $314,820. The trade was a 24.05 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Gerry Keller sold 140 shares of the stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total value of $175,572.60. Following the completion of the transaction, the insider now directly owns 6 shares of the company’s stock, valued at approximately $7,524.54. The trade was a 95.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.94% of the company’s stock.

Institutional Trading of Mettler-Toledo International

Large investors have recently bought and sold shares of the stock. UMB Bank n.a. boosted its stake in shares of Mettler-Toledo International by 6.6% in the 2nd quarter. UMB Bank n.a. now owns 113 shares of the medical instruments supplier’s stock valued at $158,000 after purchasing an additional 7 shares in the last quarter. DT Investment Partners LLC grew its stake in Mettler-Toledo International by 13.3% during the third quarter. DT Investment Partners LLC now owns 68 shares of the medical instruments supplier’s stock worth $102,000 after buying an additional 8 shares during the last quarter. Suncoast Equity Management increased its holdings in shares of Mettler-Toledo International by 2.0% during the third quarter. Suncoast Equity Management now owns 460 shares of the medical instruments supplier’s stock worth $690,000 after buying an additional 9 shares in the last quarter. Bleakley Financial Group LLC raised its stake in shares of Mettler-Toledo International by 1.2% in the third quarter. Bleakley Financial Group LLC now owns 757 shares of the medical instruments supplier’s stock valued at $1,135,000 after acquiring an additional 9 shares during the last quarter. Finally, Huntington National Bank boosted its holdings in shares of Mettler-Toledo International by 20.0% in the 3rd quarter. Huntington National Bank now owns 54 shares of the medical instruments supplier’s stock worth $81,000 after acquiring an additional 9 shares in the last quarter. 95.07% of the stock is currently owned by institutional investors.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.